Siddharth Rajkumar Jaiswal

Siddharth Rajkumar Jaiswal

Active Director Director DIN 08836711
DIN 08836711 First appointment Aug 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Total affiliations 3 Since Aug 2020
Shareholding value •••• Premium profile

About Siddharth Rajkumar Jaiswal

Data last updated:

Siddharth Rajkumar Jaiswal is a Director at Anabiosis Medisciences Limited (since 2020), Director at Alpic Remedies Limited (since 2020) and Designated Partner at Anabiosys Lifesciences Llp (since 2023). The companies operate in Pharma and Paper. The 2 current companies with reported revenue have a combined latest revenue of ₹10.48 Cr; the largest is Anabiosis Medisciences Limited at ₹6.16 Cr (FY 2023).

DIN 08836711
Primary Designation Director
Industry Pharma
First Appointment 18 Aug 2020
Oldest Company Age 25 yrs
Largest company Anabiosis Medisciences Limited · ₹6.16 Cr (FY 2023)
Combined revenue ₹10.48 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Anabiosis Medisciences Limited U24231GJ2004PLC044358
Director18 Aug 20202004₹6.16 Cr (FY 2023)Active
Alpic Remedies Limited U24231GJ2001PLC040063
Director18 Aug 20202001₹4.32 Cr (FY 2023)Active
Designated Partner31 May 20232023Active

Board colleagues of Siddharth Rajkumar Jaiswal

Directorship timeline

Open interactive timeline →
Anabiosys Lifesciences Llp
Alpic Remedies Limited
Anabiosis Medisciences Limited
Premium access

Shareholding and investment profile for Siddharth Rajkumar Jaiswal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Siddharth Rajkumar Jaiswal

Siddharth Rajkumar Jaiswal currently holds 3 directorships: Anabiosis Medisciences Limited (Director, since 18 Aug 2020, revenue ₹6.16 Cr (FY 2023)); Alpic Remedies Limited (Director, since 18 Aug 2020, revenue ₹4.32 Cr (FY 2023)); Anabiosys Lifesciences Llp (Designated Partner, since 31 May 2023).

Siddharth Rajkumar Jaiswal was first appointed on 18 Aug 2020 as Director at Anabiosis Medisciences Limited. The most recent appointment on record is 31 May 2023 at Anabiosys Lifesciences Llp.

The 2 current companies of Siddharth Rajkumar Jaiswal that report revenue have a combined latest revenue of ₹10.48 Cr: Anabiosis Medisciences Limited ₹6.16 Cr (FY 2023); Alpic Remedies Limited ₹4.32 Cr (FY 2023).

The current boards of Siddharth Rajkumar Jaiswal's companies include Jyoti Jaiswal (Anabiosis Medisciences Limited), Raj Kumar Jaiswal (Anabiosis Medisciences Limited), Ashwin Manoharlal Jaiswal (Anabiosys Lifesciences Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available